← Back to Search

Non-Invasive Continuous Remote Patient Monitoring for Heart Failure

Phase 2 & 3

Waitlist Available

Led By Nirav S Shah, MD, MPH

Research Sponsored by NorthShore University HealthSystem

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 30 days from patient discharge date

Awards & highlights

Study Summary

This trial proposes to use a wearable device to predict physiological changes and perform continuous remote patient monitoring for post-discharge care.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 30 days from patient discharge date

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~30 days from patient discharge date

This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 days from patient discharge date for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Attrition Rate

Enrollment Rate

Secondary outcome measures

30-day Readmission

Number of Participants With Diuretic Escalation

Trial Design

2Treatment groups

Experimental Treatment

Group I: Phase II: Calibration (210 days)Experimental Treatment2 Interventions

After learning from the soft launch and updating the protocol, the study will continue to enroll 15 HF patients for calibration purposes

Group II: Phase I: Soft Launch (120 days)Experimental Treatment2 Interventions

The study will conduct a soft launch on the first five HF patients enrolled to finetune process and protocol.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Non-Invasive Continuous Remote Patient Monitoring

2020

Completed Phase 3

~20

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Northwestern UniversityOTHER

1,586 Previous Clinical Trials

917,231 Total Patients Enrolled

20 Trials studying Heart Failure

4,283 Patients Enrolled for Heart Failure

NorthShore University HealthSystemLead Sponsor

132 Previous Clinical Trials

737,840 Total Patients Enrolled

1 Trials studying Heart Failure

43 Patients Enrolled for Heart Failure

physIQ, Inc.Industry Sponsor

3 Previous Clinical Trials

1,530 Total Patients Enrolled

1 Trials studying Heart Failure

400 Patients Enrolled for Heart Failure

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the aims of this experiment?

"The purpose of this 30-day clinical trial will be to measure patient adherence rates. Other indicators of success for the study include augmenting diuretic dosage, frequency of dietary counseling, and communication with care providers."

Answered by AI

Are people with the specific condition being sought for this trial able to enroll at this time?

"The clinical trial is detailed on clinicaltrials.gov and it is currently seeking participants. The study was posted on December 14th, 2020, with the last update being January 10th, 2022. There is a need for 15 individuals at a single location."

Answered by AI

How many individuals are included in this clinical trial?

"That is accurate. According to clinicaltrials.gov, this study was initially posted on December 14th 2020 and last updated on January 10th 2022. The trial is seeking 15 individuals from 1 site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

The CASCADE HF Soft Launch and Calibration Phase I and II

Nirav Shah 2020. "The CASCADE HF Soft Launch and Calibration Phase I and II". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04738279.